Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming Jefferies Global Healthcare Conference on Thursday, June 5th at 4:20pm Eastern Time (ET). Management will also be hosting in-person meetings on Wednesday, June 4th.


To schedule a one-on-one meeting with management, please reach out to your Jefferies representative, or the investor contact below.

About Hyperfine, Inc. and the Swoop® Portable MR Imaging® System

Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first U.S. Food and Drug Administration (FDA)-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit hyperfine.io.

The Swoop® Portable MR Imaging® system is FDA cleared for brain imaging of patients of all ages. It is a portable, ultra-low-field magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The Swoop® system also has CE Mark in the European Union and UKCA Mark in the United Kingdom. The Swoop® system is commercially available in a select number of international markets.

Hyperfine, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc.

Contacts

Investor Contact
Webb Campbell

Gilmartin Group LLC

webb@gilmartinir.com

Staff

Recent Posts

Walmart and Soda Health Join Forces to Deliver AI-Powered Personalized Nutrition and Wellness Insights

BENTONVILLE, Ark.--(BUSINESS WIRE)--Walmart (NYSE: WMT), the world’s leading omnichannel retailer, and Soda Health, a health…

4 hours ago

Walmart and Soda Health Join Forces to Deliver AI-Powered Personalized Nutrition and Wellness Insights

BENTONVILLE, Ark.--(BUSINESS WIRE)--Walmart (NYSE: WMT), the world’s leading omnichannel retailer, and Soda Health, a health…

4 hours ago

Protein-Packed Summer Sweet Treats

Bring joy to your health journey with quick and easy summer recipes MISSION, Kan., June…

4 hours ago

TimelyCare Earns Regional, National Nods for Workplace Excellence

FORT WORTH, Texas, June 17, 2025 /PRNewswire/ -- TimelyCare, higher education's most trusted virtual health and…

4 hours ago

Winners Announced in the 2025 Globee® Awards for Achievement

Celebrating Excellence, Innovation, and Impact Across Industries HAUPPAUGE, N.Y., June 17, 2025 /PRNewswire/ -- Makers…

4 hours ago

Skytale Group Introduces Revenue Cycle Management (RCM) Consulting Services to Enhance Financial Performance for Dental and Healthcare Organizations

DALLAS, June 17, 2025 /PRNewswire/ -- Skytale Group, a trusted boutique investment banking and management…

4 hours ago